Whartons Jelly Derived Mesenchymal Stem Cells

According to the authors of the review these stem cells can be collected during millions of births each year at the time of delivery.

Whartons jelly derived mesenchymal stem cells.

Around 5 million annual births in eu and 131 million worldwide give a unique opportunity to collect lifesaving wharton s jelly derived mesenchymal stem cells wj msc. 2 polish stem cell bank grzybowska 2 41 00 131 warsaw poland. A recent publication in biomed research international has reviewed the study on the potential benefits of wharton s jelly derived mesenchymal stem cells in treating a variety of diseases. Wharton s jelly derived mesenchymal stem cells wj mscs have a high proliferation valency and they do not produce teratogen or carcinogen after subsequent transplantation.

Thus more research is needed on the isolation and characterization of mesenchymal ste. We report a 16 year old boy who was treated with wj mscs in the course of hie due to post cardiopulmonary resuscitation. Wharton s jelly is therefore a potential source of adult stem cells often collected from cord blood. Evidences that these cells possess therapeutic properties are constantly accumulating.

In a recent study wharton s jelly tissue transplantation has shown to be able to reduce traumatic brain injury and may have therapeutic potential. They are known as regenerative medicine.